Y-Intercept (HK)’s Asensus Surgical, Inc. ASXC Stock Holding History

Y-Intercept (HK)’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-31,620	Closed	-$13K	–	1344
2022 Q2	$13K	Buy	+31,620	New	+$14.1K	﹤0.01%	806

Other funds holding ASXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Y-Intercept (HK)'s ASXC Position: Q3 2022 in Review

Y-Intercept (HK) sold out of Asensus Surgical, Inc. (ASXC) in Q3 2022, closing a stake of 31,620 shares — an estimated $13K sold.

Y-Intercept (HK) first reported a position in ASXC in Q2 2022 and held it in 1 quarter. The position peaked at $13K in Q2 2022. 82 funds tracked by Wall St. Rank hold ASXC as of Q3 2022.

Y-Intercept (HK) reported no remaining Asensus Surgical, Inc. position as of Q3 2022 after selling out during the quarter.
Y-Intercept (HK) sold 31,620 Asensus Surgical, Inc. shares in Q3 2022, an estimated $13K.
Y-Intercept (HK) first reported a position in Asensus Surgical, Inc. in Q2 2022 and held it in 1 quarter.
Y-Intercept (HK)'s Asensus Surgical, Inc. position peaked at $13K in Q2 2022.
82 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2022.

Based on Y-Intercept (HK)'s 13F filing for Q3 2022, filed 14 Feb 2023.